2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z

Nasal septum deviation correlates with asymmetry in Parkinson’s disease

J. Wang, J. Wang, F. Liu, C. Zuo, Y. Sun, J. Wu (Shanghai, China)
National Survey of DYT/PARK-GCH1 (Segawa Disease) in Japan

K. Hoshino, M. Kawai, Y. Nagao, M. Nozaki, Y. Yatomi, Y. Hirano, M. Fukumizu, I. Kawahata, H. Shintaku, K. Kimura, M. Hayashi (Osaka, Japan)
Natural compound Protects Dopaminergic Neurons by Targeting Oxidative Stress and Cell Death Pathways in Parkinson’s Disease

S. Pandey, R. Singh (Lucknow, India)
Natural history and epidemiological study of multiple system atrophy in Hokkaido: HoRC-MSA 2014-2025

M. Matsushima, K. Sakushima, Y. Kanatani, N. Nishimoto, J. Sawada, T. Matsuoka, H. Uesugi, N. Minami, K. Sako, A. Takei, S. Hisahara, A. Tamakoshi, N. Sato, I. Yabe (Sapporo, Japan)
Needs assessment and initial implementation of a Movement Disorders curriculum for Neurology residents

M. Thapa, H. Kaur, N. Chunga (Shreveport, USA)
Negative Correlation between Apathy and Executive Functioning in Patients with Idiopathic Parkinson’s Disease without Dementia.

P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospinta-Otalvaro, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, A. Maria Valencia-Orjuela (Cali, Colombia)
Negative Correlation Between Apathy and Performance on Memory Tasks in Patients with Idiopathic Parkinson’s Disease without Dementia.

J. Felipe Ayala-Rico, C. Alberto Hurtado-González, S. Ospinta-Otalvaro, P. Andrea Gutiérrez-Lenis, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, K. Valbuena-Epiayu (Cali, Colombia)
Neural Correlates of Impaired Apathy Self-awareness in Parkinson’s Disease

H. Conn, H. Suzuki, Z. Jin, A. Marin, Y. Gazes, S. Lee, S. Heilbronner, N. Vanegas-Arroyave (Houston, USA)
Neural Correlates of Rhythmic Auditory Stimulation Responsiveness in Parkinson’s Disease: A Pilot Gait and fMRI Study

CY. Chien, CL. Lin, JSK. Chang, YH. Liu, SC. Wang, CC. Lin (Tainan, Taiwan)
Neural Mechanisms of Intermittent Theta Burst Stimulation for Depressive Symptoms in Parkinson’s Disease: Insights from fNIRS-Based Cortical Activation and Connectivity Dynamics

Y. Zhang, M. Hou, Z. Liu (Shanghai, China)
Neural Network Models Predict Parkinson’s Disease Using Brief-Action Motion Sensor Data

S. Panchawagh, Z. Zibly, V. Santini (Pune, India)
Neural Signatures of Hallucination Emergence in Dementia with Lewy Bodies

R. Vin, S. Moret, HY. Yi, M. Lawrence, V. Santini, J. Cedarbaum, A. Powers, C. Fredericks (New Haven, USA)
Neurite Orientation Dispersion and Density Imaging revals reveals white matter microstructural changes in isolated REM sleep behavior disorder

E. Mak, S. Przybelski, R. Reid, A. Fought, C. Schwarz, P. Vemuri, C. Jack JR., Y. Nie, H. Delacruz, A. Avidan, D. Bliwise, M. Campbell, S. Criswell, A. Davis, K. Duff, K. Ehgoetz Martens, J. Elliot, T. Ferman, J. Fields, L. Forsberg, J. Gagnon, Z. Gan-Or, M. Howell, M. Hu, X. Hu, D. Huddleston, P. Kotzbauer, J. Langley, M. Lim, J. Locke, V. Lowe, S. Mccarter, J. Mcleland, M. Miglis, E. Mignot, T. Miyagawa, L. Neilson, K. Nichols, A. Pelletier, O. Ross, C. Schenck, S. Wolfgang, E. ST. Louis, L. Trotti, A. Videnovic, C. Xiong, R. Postuma, Y. Ju, B. Boeve, K. Kantarci (Rochester, USA)
Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.

C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Rivera-Quintero (Cali, Colombia)
Neurodegeneration Biomarkers: Correlation between Hippocampal Volume and Cognitive Performance by MoCA Test in Parkinson’s Disease

Y. Matuk Perez, E. Fernandez Calleja, D. Resendiz Gonzalez, JM. Esquivias Farías, S. Alcauter Solórzano, I. Zamorano-Rangel (Queretaro, Mexico)
Neurodegenerative Langerhans Cell Histiocytosis: A Rare Cause of Cerebellar Ataxia

C. Onuigbo, S. Pradeep (Houston, USA)
Neurogenic bladder and affective disorders in parkinsonism

E. Korshunova, M. Khommyatov, M. Samushiya, N. Suponeva (Moscow, Russian Federation)
Neuroimaging abnormalities of the striatopallidal regions in people with diabetes: A single-center retrospective study

N. Chunga, A. Gershteyn, K. Palermo-Cruz, R. Ramchandran, G. Schifitto, K. Lizarraga (Rochester, USA)
Neuroimaging and CSF Correlates of Minor Hallucinations in Parkinson’s Disease

E. Hacılar, B. Samancı, U. Ay, S. Yörük, E. şahin, M. Alaylıoğlu, E. Kurt, E. Dursun, H. Gürvit, B. Bilgiç, D. Gezen-Ak, T. Demiralp, H. Hanağası (Istanbul, Turkey)
Neuroinflammatory response is determined by HLA genotype in progressive supranuclear palsy

G. Kovacs, H. Chasiotis, S. Zaheer, J. Wang, J. Li, MC. Tartaglia, S. Fox, A. Lang, S. Forrest (Toronto, Canada)
Neurologic Music Therapy and Non-Invasive Brain Stimulation for Upper Extremity Performance in Patients with Corticobasal Syndrome

K. Kang, I. Sterner, S. Bakhshi, C. Bedell, A. Pantelyat (Baltimore, USA)
Neurological manifestations and genotypes of Gaucher disease type 3: MDSGene systematic review

S. Schaake, T. Usnich, J. Boehm, N. Steffen, N. Schell, C. Krüger, T. Gül-Demirkale, N. Bahr, T. Kleinz, H. Madoev, B. Laabs, Z. Gan-Or, R. Alcalay, C. Marras, K. Lohmann, C. Klein, M. Rossi (Luebeck, Germany)
Neuron-Derived Extracellular Vesicles as Biomarkers of Iron Dysregulation in Restless Legs Syndrome: A Link to Neurodegeneration

S. Buggana, S. Yadav (Tirupati, India)
Neuronal DJ-1 regulates microglia activation via ADAM10-mediated CX3CL1 secretion

A. Zhao, Y. Jiao, J. Liu, Y. Li (shanghai, China)
Neurophysiological research on inhibitory processes in Parkinson’s disease

S. Parmigiani, K. Shultz, N. Swann, . , . (Eugene, USA)
Neuroprotection on the Horizon: Are GLP-1 Receptor Agonists the Next Breakthrough in Parkinson’s Disease?

M. Helal, H. Aboushawareb, O. Hussein Abbas, R. Haddad, Y. Zain, A. S.A Osman, N. Hamam, A. Hassan (Zagazig, Egypt)
Neuroprotective Effects of ATP6V0C Overexpression in PFF Model Mice

Y. Wang, Y. Xia, L. Kou, T. Wang (wuhan, China)
Neuroprotective Effects of Co-Administered Hesperetin and Resveratrol Nanoparticles on Oxidative Stress and Neurobehavioral Deficits in Parkinson’s Disease

R. Rajput, S. Verma (Agra, India)
Neuroprotective Effects of Thymol in MPTP-Induced Parkinson’s Disease Model in Rats: Molecular Docking, Behavioral, Biochemical, and Histological Investigations

A. Kumar, V. Malhotra (Ahamdabad, India)
Neuroprotective efficacy of EDTA against manganese neurotoxicity: Implications for modulating Parkinsonian syndromes

H. Harifi, H. Hami, L. Bikjdaouene (Kenitra, Morocco)
Neuroprotective Role of Diosgenin-Loaded Lipid Nanoparticles for Parkinson’s Disease: Pharmacokinetic and Pharmacodynamic Insights

R. Rajput, S. Verma (Agra, India)
Neuropsychiatric profile of progressive supranuclear palsy phenotypes

V. Martinez-Villota, L. Ortega-Bolaños, M. Rodríguez-Violante (Pasto, Colombia)
Neutrophil Extracellular Traps Reveal Novel Inflammatory Signatures in Parkinson’s Disease and Multiple System Atrophy

C. Ying, M. Zhang, H. Zhang, Y. Li, W. Mao, Y. Cai (Beijing, China)
NIH funds Gut-Brain Parkinson’s Disease Consortium

C. Goetz, L. Becker, A. Bharucha, E. Chang, A. Keshavarzian, B. Kuo, K. Newby, K. Poston, L. Sanders, R. Savica, A. Sharma, A. Videnovic, L. Wruck, T. Xie (Chicago, USA)
Noise assessment acoustic measures of sustained vowel in patients with Parkinson’s disease

I. Khasanov, D. Khasanova (Kazan, Russian Federation)
Non-Motor Fluctuations In Parkinson’s Disease: A Cross-Sectional Study On Prevalence, Correlates, And Impact On Quality Of Life

K. B K, A. Mehta, P. R, M. Javali, L. Priya, P. Acharya (Bengaluru, India)
Non-Motor Symptom Comparisons by Race/Ethnicity in Thousands with PD Diagnosis

G. Smith, R. Schneider, L. Stamm, P. Auinger, C. Venuto (Rochester, USA)
Non-motor Symptoms in Parkinson Disease: A Target for Neuropalliative Care Intervention

J. Acquaviva, S. Maguire, Y. Xu, E. Feinstein (Newark, USA)
Non-motor Symptoms, Sleep Disturbances, And Genetic Insights In Young Onset Parkinson’s Disease: A Prospective Descriptive Study

L. Sahoo, V. Choudhary, A. Mishra (Bhubaneswar, India)
Noradrenaline treatment of apathy and impulsivity in participants with Progressive Supranuclear Palsy syndromes (NORAPS)

R. Durcan, H. Paula, D. Street, A. Murley, S. Jones, A. Church, C. Kobylecki, V. Marshall, C. Antoniades, B. Ghosh, J. Rowe (Cambridge, United Kingdom)
Normal Pressure Hydrocephalus in Vestibular Schwannoma Patients

T. Davidy, S. Anis, T. Goldberg, A. Fay-Karmon, Y. Zauberman, N. Rennert, O. Lesman-Segev, S. Hassin-Baer (Cleveland, USA)
Novel C-KIT/C-Abl Inhibitor BK40196 Alleviates Neurodegenerative Pathology And Improves Behavioral Performance In A53T Mice

X. Liu, M. Hebron, M. Stevenson, C. Moussa (Washington, USA)
Novel CUX2 Mutation Identified in Patient with Clinical Paroxysmal Nonkinesigenic Dyskinesia

C. Cheung, G. Osaki Mark, K. Mackenzie (Elk Grove, USA)
Novel DCC Variant Identified to Cause Congenital Mirror Movements

M. Rochman, J. Ratliff (Phialdelphia, USA)
Novel findings in a Swedish RFC1-related disorder cohort

V. Alm, L. Verrecchia, M. Paucar (Huddinge, Sweden)
Novel Genetic Variant Associated with Parkinsonism

B. Daud Shah, E. Noyes, S. Giri Ravindran, A. Rajput (Saskatoon, Canada)
Novel Heterozygous Variant in DCTN1 Associated with Perry Syndrome

D. Yang, Y. Zhang, Z. Cen, W. Luo (Hangzhou, China)
Novel heterozygous variant in VPS13A: First case report of choreoacanthocytosis in northern México

L. Hernández Salomón, S. Flores Casas, J. Mejía Chávez, S. Murillo Quintana, D. Sánchez Galván (Torreón, Coahuila, Mexico)
Novel Insights into the Association Between Parkinson’s Disease and Constipation: Role of SHMT2 as a Promising Biomarker

JH. Su, EX. Tao (Shenzhen, China)
Novel Multiple System Atrophy Subtypes Identified Using Unsupervised Machine Learning Algorithms

H. Sekiya, D. Ono, A. Maier, D. Dickson (Jacksonville, USA)
Novel Parkinson’s Disease Genetic Risk Factors Within and Across European Populations

GP2. Parkinson'S_genetics_program (Bethesda, USA)
Novel presentation of PRRT2 with paroxysmal dystonia and responsive to carbidopa/levodopa.

J. Cremin-Endes, M. Walsh, M. Higginson, N. Hack (San Diego, USA)
Novel SPTAN1 Variant in Adult-Onset Cerebellar Ataxia in Active Duty Military Member

M. Graham, J. Jacobson, L. Rohena (Fort Sam Houston, USA)
Novel Technologies for REM Sleep Behavior Disorder Detection to Identify Prodromal Parkinson’s Disease at Home

K. Colman, F. Dijkstra, D. Crosiers, I. de Volder, J. Verbraecken, AM. Schyvens, M. Viaene, O. Wolfgang, A. Pijpers (Edegem, Belgium)
Novel Usage of Alpha Synuclein as a Biomarker for Screening Parkinson’s disease at Komfo Anokye Teaching Hospital in Ghana

YAW. Osei, SF. Sarfo, FAY. Yeboah Agyemang (Kumasi, Ghana)
Nutrition, Motor And Non-Motor Symptoms Impact On Life’s Quality In Parkinson’s Disease In Second-Line Therapies

N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes, B. Tijero, M. Ruiz-Lopez, T. Fernandez-Valle, J. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)
Nutritional Parameter Changes in Parkinson’s Disease Patients Receiving Continuous Subcutaneous Infusion of Foslevodopa-Foscarbidopa

M. Barichella, MC. Macchione, G. Lazzeri, E. Cereda, I. Ioannis, G. Pezzoli (Milano, Italy)

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z